Showing results (191-200 of 241) with videos related to
Sort By:
Pageof 25
Clinical and Experimental Rheumatology|August 19, 2000
Is high titre ANA specific for connective tissue disease?J H Vaile, L Dyke, R Kherani, et al.Clinical and Investigative Medicine. Medecine Clinique Et Experimentale|October 1, 1995
Small bowel permeability--a variable effect of NSAIDSV M Choi, J E Coates, J Chooi, et al.British Journal of Rheumatology|February 1, 1995
Incidence of myopathy in patients treated with antimalarials. A report of three cases and a review of the literatureJ A Avina-Zubieta, E S Johnson, M E Suarez-Almazor, et al.Journal of Pharmaceutical Sciences|March 1, 1992
Human pharmacokinetics of ibuprofen enantiomers following different doses and formulations: intestinal chiral inversionF Jamali, R Mehvar, A S Russell, et al.Annals of Internal Medicine|March 1, 1976
Bone scintiscanning updatedB C Lentle, A S Russell, J S Percy, et al.Lupus|October 1, 1995
Clinical evaluation of various selected ELISA kits for the detection of anti-DNA antibodiesJ A Aviña-Zubieta, G Galindo-Rodriguez, L Kwan-Yeung, et al.Clinical Therapeutics|May 1, 1994
Patient compliance with tenoxicam in family practiceG R Kraag, D A Gordon, H A Ménard, et al.The Journal of Rheumatology|November 11, 1999
Assessment of health locus of control in the use of nonconventional remedies by patients with rheumatic diseasesC Ramos-Remus, C A Watters, L Dyke, et al.The Journal of Rheumatology|January 26, 1999
Bowel permeability and CD45RO expression on circulating CD20+ B cells in patients with ankylosing spondylitis and their relativesJ H Vaile, J B Meddings, B R Yacyshyn, et al.The Journal of Rheumatology|April 29, 1998
An open study of pamidronate in the treatment of refractory ankylosing spondylitisW P Maksymowych, G S Jhangri, S Leclercq, et al.Pageof 25